Burning Rock Biotech Files December 2025 6-K
Ticker: BNR · Form: 6-K · Filed: Dec 1, 2025 · CIK: 1792267
Sentiment: neutral
Topics: agm, shareholder-meeting, filing
TL;DR
Burning Rock Biotech filed its December 6-K with AGM docs, check your proxy.
AI Summary
Burning Rock Biotech Limited filed a Form 6-K on December 1, 2025, for the month of December 2025. The filing includes a press release, notice of the Annual General Meeting, and proxy materials for ADS holders. The company is registered in the People's Republic of China and its principal executive offices are located in Guangzhou, Guangdong.
Why It Matters
This filing provides shareholders with essential documents for the upcoming Annual General Meeting, including voting instructions and meeting notices.
Risk Assessment
Risk Level: low — This filing is routine administrative and shareholder communication, not indicating new financial or operational risks.
Key Players & Entities
- Burning Rock Biotech Limited (company) — Registrant
- 001-39316 (other) — Commission File Number
- December 1, 2025 (date) — Filing Date
- Guangzhou, Guangdong (location) — Principal Executive Offices
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer for the month of December 2025, including a press release and materials related to the Annual General Meeting.
When was this filing submitted to the SEC?
The filing was submitted on December 1, 2025.
Where is Burning Rock Biotech Limited's principal executive office located?
The principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
What exhibits are included with this 6-K filing?
The exhibits include a press release (99.1), Notice of Annual General Meeting (99.2), Form of Proxy (99.3), and Form of Voting Card for ADS Holders (99.4).
Does Burning Rock Biotech file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under Form 20-F.
Filing Stats: 171 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2025-12-01 09:56:48
Filing Documents
- d18012d6k.htm (6-K) — 10KB
- d18012dex991.htm (EX-99.1) — 8KB
- d18012dex992.htm (EX-99.2) — 14KB
- d18012dex993.htm (EX-99.3) — 15KB
- d18012dex994.htm (EX-99.4) — 21KB
- 0001193125-25-303306.txt ( ) — 69KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: December 1, 2025